| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/20/2001 | US6203991 Inhibition of smooth muscle cell migration by heme oxygenase I |
| 03/20/2001 | US6203979 Polynucleotide which codes for protein of defined amino acid sequences; diagnosis, prevention, and therapy of cell proliferative and immune disorders; anticarcinogenic agents; antiproliferative/antiarthritic agents; crohn's disease |
| 03/20/2001 | US6203976 Drug screening using eukaryotic cells with dna construct of regulatory sequence and promoter linked to reporter gene, contacting with chemical, quantitatively determining signal produced, comparing to controls, then mixing with carrier |
| 03/20/2001 | US6203820 Comprising molybdenum and at least two amino acids selected from l-arginine, l-cystine, l-histidine, l-isoleucine, l-leucine, l-lysine, l-methionine, l-phenylalanine, l-threonine, l-tryptophan, l-tyrosine, and l-valine |
| 03/20/2001 | US6203805 Topical compositions containing whey proteins |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203797 Freeze dried aloe, vitamin b6 hydrochloride, manganes, glutamine, fructooligosaccharides and dahlia inulin juice |
| 03/20/2001 | US6203795 Polypeptide; antibody h23 recognizes tumor antigen expressed on breast cancer cells |
| 03/20/2001 | US6203794 Botulinum or tetanus toxin conjugated to drug; treating neurvous system and muscular disorders |
| 03/20/2001 | US6203793 Compositions and methods for treating thermal injury |
| 03/20/2001 | US6203792 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof |
| 03/20/2001 | US6203790 Genetic engineering; antiinflammatory agents |
| 03/20/2001 | US6203789 Treating erythrocytes with s-nitroso-cysteine, homocysteine, or cysteinylglycine to reduce blood pressure |
| 03/20/2001 | US6203788 Implanting cellular adhesion molecule and schwann or oligodendrocyte progenitor cell(s); inhibiting n-cadherin-mediated cell adhesion; treating muliple sclerosis |
| 03/20/2001 | US6203787 Treating tumors using implants comprising combinations of allogeneic cells |
| 03/20/2001 | CA2102429C Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| 03/20/2001 | CA2098303C Synthetic bioadhesive polypeptide |
| 03/20/2001 | CA2070169C Compounds with a sequence of three radicals, the central one being -aminoacidic and therapeutical applications thereof |
| 03/20/2001 | CA1341207C Analogues of insulin-like growth factor-1 |
| 03/20/2001 | CA1341206C Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| 03/15/2001 | WO2001018550A2 Determination of adrenomedullin-binding proteins |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018541A1 Use of beta2gpi in diagnostic tests for autoimmune diseases |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018227A1 Novel compound f-15078 |
| 03/15/2001 | WO2001018224A1 Adenoviral vectors modified for increased and persistent expression of the cystic fibrosis transmembrane conductance regulator gene in human airway epithelia |
| 03/15/2001 | WO2001018216A2 26176, a novel calpain protease and uses thereof |
| 03/15/2001 | WO2001018215A1 Method for producing active serine proteases and inactive variants |
| 03/15/2001 | WO2001018212A2 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018209A1 Fibroblast growth factor polypeptide and nucleic acids encoding same |
| 03/15/2001 | WO2001018208A2 Interferon induced polynucleotides and proteins encoded thereby |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018202A2 Flint analog compounds and formulations thereof |
| 03/15/2001 | WO2001018200A1 Tsg-like gene |
| 03/15/2001 | WO2001018184A1 Variant nucleoside-5'-phosphate producing enzyme |
| 03/15/2001 | WO2001018178A1 Nucleic acids and polypeptides of invertebrate bioamine transporter and methods of use |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018055A1 Flint analog compounds and formulations thereof |
| 03/15/2001 | WO2001018053A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 03/15/2001 | WO2001018052A1 Monomeric analogues of human insulin |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018046A2 Ovarian tumor sequences and methods of use therefor |
| 03/15/2001 | WO2001018044A2 Use of semaphorin for modulation of cellular efflux |
| 03/15/2001 | WO2001018043A2 Neurogenic compositions and methods |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018041A2 Flint proteins and formulations thereof |
| 03/15/2001 | WO2001018040A2 Use of leptin in inhibition of endothelial cell proliferation |
| 03/15/2001 | WO2001018039A2 INCREASED PRODUCTION OF INTERFERON-$g(a) |
| 03/15/2001 | WO2001018038A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | WO2001018037A2 A p53-induced protein with a death domain that can promote apoptosis |
| 03/15/2001 | WO2001018036A2 Methods and reagents for regulating gene expression |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018030A2 Small peptides having potent anti-angiogenic activity |
| 03/15/2001 | WO2001018024A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | WO2001018023A1 Antisense modulation of pi3 kinase p110 beta expression |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018019A1 Epithelial protein lost in neoplasm (eplin) |
| 03/15/2001 | WO2001018018A1 Murf gene and enzyme ofpseudomonas aeruginosa |
| 03/15/2001 | WO2001017995A1 Tyrosine kinase inhibitors |
| 03/15/2001 | WO2001017985A1 Novel derivatives of flavones, xanthones and coumarins |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017563A2 Integrin-mediated drug targeting |
| 03/15/2001 | WO2001017559A1 Semaphorin modulation of immune cell migration |
| 03/15/2001 | WO2001017558A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | WO2001017557A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 03/15/2001 | WO2001017552A1 Kaposi's sarcoma-associated herpesvirus ks-sm gene product and uses thereof |
| 03/15/2001 | WO2001017548A2 Use of natriuretic peptides as antibiotically effective substances for treating bacterial infections |
| 03/15/2001 | WO2001017547A2 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons |
| 03/15/2001 | WO2001017546A1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 03/15/2001 | WO2001017545A1 Remedies for nervous diseases |
| 03/15/2001 | WO2001017544A1 Peptides that bind to urokinase receptor |
| 03/15/2001 | WO2001017543A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 03/15/2001 | WO2001017541A1 Composition for extending post meal satiety |
| 03/15/2001 | WO2001017538A1 Use of oyster flesh enzymatic hydrolysates for preparing compositions eliminating free radicals |
| 03/15/2001 | WO2001017536A2 Novel autogenous vaccines used to obtain an immune tolerance |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2001017524A1 Methods for treating cell proliferative disorders including cancer |
| 03/15/2001 | WO2001017522A1 Method of treating cancer using tetraethyl thiuram disulfide |
| 03/15/2001 | WO2001017506A1 Proteinic drug delivery system using membrane mimetics |
| 03/15/2001 | WO2001017480A2 Methods and compositions for preventing and treating urinary tract disorders |
| 03/15/2001 | WO2001017479A2 Methods and compositions for preventing and treating prostate disorders |
| 03/15/2001 | WO2001017369A1 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of 'fast sugars' |
| 03/15/2001 | WO2001002429A3 Angiopoietin-6 and uses thereof |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000071152A9 Fibroblast growth factor 10 |
| 03/15/2001 | WO2000069425A3 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000064468A3 Therapeutic compositions and methods for enhancing angiogenesis |
| 03/15/2001 | WO2000061610A3 Prostate-restricted gene 30p3c8 expressed in prostate cancer |